EACO Corporation (EACO)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	7.27	0.84	8.56	17.39	4.46	6.08
Trading Asset Securities	22.06	14.75	27.23	3.93	3.74	1.37
Cash & Short-Term Investments	29.33	15.59	35.79	21.31	8.2	7.45
Cash Growth	189.22%	-56.43%	67.92%	160.02%	10.06%	13.44%
Receivables	57.85	53.27	46.65	44.64	33.93	29.67
Inventory	82.78	69.6	56.27	48.81	40.45	39.55
Prepaid Expenses	3.49	3.53	3.84	5.01	6.78	5.09
Restricted Cash	0.01	0.01	0.01	0.01	0.01	2.92
Total Current Assets	173.46	142	142.56	119.77	89.36	84.67
Property, Plant & Equipment	41.11	42.57	18.03	18.87	19.35	21.66
Long-Term Deferred Tax Assets	-	-	-	-	-	0.87
Other Long-Term Assets	3.99	3.96	1.65	1.04	1.67	0.55
Total Assets	218.56	188.54	162.24	139.68	110.39	107.75
Accounts Payable	38.7	28.05	22.51	21.76	16.41	16.54
Accrued Expenses	15.93	24.91	16.38	15.02	10.96	6.63
Current Portion of Long-Term Debt	0.13	0.13	0.12	0.12	0.11	5.1
Current Portion of Leases	2.67	2.71	3.95	3.38	3.1	2.65
Other Current Liabilities	-	-	-	-	-	2.92
Total Current Liabilities	63	55.8	42.95	40.28	30.59	33.84
Long-Term Debt	4.61	4.21	4.35	4.47	4.59	4.81
Long-Term Leases	4.22	4.89	6.23	7.19	8.09	10.29
Total Liabilities	71.83	64.91	53.52	51.93	43.26	48.93
Common Stock	0.05	0.05	0.05	0.05	0.05	0.05
Additional Paid-In Capital	12.38	12.38	12.38	12.38	12.38	12.38
Retained Earnings	134.24	111.13	96.26	75.15	53.91	45.6
Comprehensive Income & Other	0.07	0.07	0.04	0.17	0.78	0.79
Total Common Equity	146.73	123.63	108.72	87.75	67.12	58.82
Shareholders' Equity	146.73	123.63	108.72	87.75	67.12	58.82
Total Liabilities & Equity	218.56	188.54	162.24	139.68	110.39	107.75
Total Debt	11.63	11.94	14.64	15.15	15.89	22.85
Net Cash (Debt)	17.7	3.65	21.14	6.16	-7.69	-15.4
Net Cash Growth	1517.82%	-82.75%	243.23%	-	-	-
Net Cash Per Share	3.61	0.74	4.31	1.27	-1.58	-3.17
Filing Date Shares Outstanding	4.86	4.86	4.86	4.86	4.86	4.86
Total Common Shares Outstanding	4.86	4.86	4.86	4.86	4.86	4.86
Working Capital	110.47	86.2	99.61	79.5	58.78	50.83
Book Value Per Share	30.18	25.43	22.36	18.05	13.81	12.10
Tangible Book Value	146.73	123.63	108.72	87.75	67.12	58.82
Tangible Book Value Per Share	30.18	25.43	22.36	18.05	13.81	12.10
Land	-	13.16	-	-	-	-
Buildings	-	18.71	-	-	-	-
Machinery	-	15.65	14.39	13.91	13.26	12.62
Construction In Progress	-	-	0.65	0.5	0.1	0.08
Leasehold Improvements	-	2.77	7.73	7.41	6.74	6.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.